MDWD · MediWound Ltd.
Market Cap
$162.93M
Shares
12.91M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$16.96M
-16.1%
FY2025
Net Income
-$23.88M
+21%
FY2025
Gross Margin
19.19%
+6.2pp
FY2025
Operating Margin
-148.98%
-53pp
FY2025
Diluted EPS
-$2.10
+30.7%
FY2025
Operating Cash Flow
-$16.12M
-18.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $16.96M | $20.22M | $18.69M | $26.5M | $23.76M | $21.76M | $31.79M | $3.4M | $2.5M | $1.56M | $601K | |
| $13.71M | $17.59M | $15.11M | $13.33M | $14.99M | $14.22M | $11.85M | $2.09M | $1.58M | $2.16M | $2.52M | |
| $3.25M | $2.63M | $3.58M | $13.17M | $8.77M | $7.55M | $19.94M | $1.31M | $918K | -$600K | -$1.92M | |
| 19.19% | 13.03% | 19.15% | 49.69% | 36.91% | 34.67% | 62.73% | 38.61% | 36.78% | -38.51% | -319.13% | |
| $14.32M | $8.88M | $7.47M | $10.18M | $10.26M | $7.7M | $4.97M | $4.07M | $5.46M | $7.07M | $6.02M | |
| $511K | $411K | $356K | $385K | $490K | $282K | $200K | $192K | $236K | $111K | $180K | |
| $591K | $630K | $672K | $426K | $559K | $387K | $512K | $474K | $457K | $475K | $417K | |
| -$25.27M | -$19.4M | -$15.29M | -$8.35M | -$11.22M | -$8.84M | $4.49M | -$3.96M | -$13.69M | -$20.16M | -$21.23M | |
| -148.98% | -95.94% | -81.83% | -31.5% | -47.22% | -40.62% | 14.13% | -116.44% | -548.36% | -1293.65% | -3531.95% | |
| -$24.68M | -$18.77M | -$14.62M | -$7.92M | -$10.66M | -$8.45M | $5.01M | -$3.49M | -$13.23M | -$19.68M | -$20.81M | |
| $2.46M | $12.81M | $1.89M | $11.64M | $2.31M | $1.28M | $2.98M | $2.12M | $1.25M | $896K | $1.5M | |
| -$23.71M | -$30.16M | -$6.53M | -$19.52M | -$13.52M | -$9.28M | $2.07M | — | — | — | — | |
| $169K | $61K | $185K | $78K | $27K | $0 | $0 | — | — | — | — | |
| -$23.88M | -$30.22M | -$6.72M | -$19.6M | -$13.55M | -$9.2M | $4.96M | -$1.06M | -$22.15M | -$18.89M | -$22.09M | |
| -140.8% | -149.46% | -35.94% | -73.97% | -57.03% | -42.26% | 15.59% | -31.08% | -887.38% | -1212.13% | -3675.21% | |
| USD/shares | -$2.10 | -$3.03 | -$0.75 | -$3.93 | -$3.48 | -$2.38 | — | — | — | — | — |
| USD/shares | -$2.10 | -$3.03 | -$0.75 | -$3.93 | -$3.48 | -$2.38 | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts
CIK
1593984
CUSIP
M68830112
13F (30d)
60 filings
59 filers
Visit website
Investor relations